Skip to main content
OpenTrials

Clinical trial condition

Rheumatic Diseases

Explore clinical trials studying Rheumatic Diseases. Study availability and eligibility vary by location and protocol.

8,106 public trials 951 recruiting studies
Refine in advanced search Browse all conditions

Rheumatic Diseases trial results

Completed

A Study for Adult Patients With Fibromyalgia

NCT00965081

Conditions
Fibromyalgia, Fibromyalgia, Primary, Fibromyalgia, Secondary, +5 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mérida, Mexico
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Monterrey, Mexico
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morelia, Mexico
View Trial Details
Completed

Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis

NCT01078571

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Site Reference ID/Investigator# 29714 A Coruña, Spain
  • Site Reference ID/Investigator# 29061 Algeciras, Spain
  • Site Reference ID/Investigator# 29710 Almería, Spain
  • Site Reference ID/Investigator# 29719 Barcelona, Spain
View all 40 locations
View Trial Details
Completed

Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

NCT01328522

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Investigational Site Number 840003 Beverly Hills, California, United States
  • Investigational Site Number 840001 Ocala, Florida, United States
  • Investigational Site Number 840004 Duncansville, Pennsylvania, United States
  • Investigational Site Number 840002 Dallas, Texas, United States
View Trial Details

Related conditions